Fullard, 31, who had been in custody in Hull, was originally due to face a trial but he later admitted 15 offences, including ...
Takeda (TSE:4502/NYSE:TAK) today announced that the recently FDA-approved HyHub and HyHub Duo devices are now available in the U.S. for patients 17 years of age and older, as prescribed, who are ...
Soaring costs of fertility treatment are driving a growing number of women to use online forums to realise their dreams of ...
Recommendation based on TULIP-SC Phase III trial results showing first-in-class Saphnelo reduced disease activity via once-weekly subcutaneous administration AstraZeneca's Saphnelo (anifrolumab) has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback